Preclinical Evidence for the Efficacy of CD79b Immunotherapy in B-cell Precursor Acute Lymphoblastic Leukemia.

ABSTRACT:

SUBMITTER: Lenk L 

PROVIDER: S-EPMC9351922 | biostudies-literature | 2022 Aug

REPOSITORIES: biostudies-literature